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Aim: Late radiation injury in the form of radiation-induced fibrosis (RIF) is one of the many complications of radiation therapy. 
The aim was to evaluate oxygen perfusion in the skin in the area of late radiation injury manifested as RIF in patients with breast 
cancer. Materials and Methods: Based on our first-hand experience in treating late radiation injures of soft tissues in patients with 
breast cancer, we measured oxygen perfusion of the skin (tсрО2) in the area of late radiation injury using a transcutaneous monitor 
(oximeter) TCM 400 (Radiometer, Denmark). Results: Partial oxygen pressure tcpO2 in the RIF area in patients with breast cancer 
didn’t show any significant decrease compared to healthy tissue. Mean value of partial oxygen pressure tcpO2 in the RIF area was 
42.650 ± 9.178 mmHg, in the healthy tissue it was 45.180 ± 8.025 mmHg. Maximal difference in tcpO2 between the damaged 
and healthy tissue was 30 mmHg. Conclusions: Results of the study suggest that there’s no significant difference between oxygen 
perfusion (tcpO2) in the area of RIF and healthy tissue.
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Radiation therapy remains one of the most effec-
tive and useful methods of treatment of malignant 
tumors, breast cancer in particular [1, 2]. Current 
understanding of ionizing radiation dose tolerance 
for various organs and tissues, improvement of regi-
men durations, as well as advancement of radiation 
sources, allow to achieve significant antitumor ef-
fect. However, during radiation therapy, not only 
tumor cells are damaged, but also healthy tissue, 
and there’s a risk of radiation injury (RI) in the irradi-
ated area leading to consistent changes in organs 
and tissues. These changes can significantly de-
crease patients’ quality of life even after recovery. 
One of the many complications of radiation therapy 
is late RI manifesting as radiation-induced fibrosis 
(RIF) [1, 3, 4].
RI can be early if it develops in the first three months 
after irradiation and late if it manifests later.
In literature, RIF pathogenesis is considered from 
several points of view. According to one of the hypo-
theses, the main cause of RIF pathogenesis is RI of the 
vessels due to ionizing radiation, especially capil-
lary endothelium. At first, RI manifests as functional 
patholo gy of microcirculation and hypoxia in the irradi-
ated tissue, and later it leads to morphological chang-
es in the cells and formation of late manifestations 
of irradiation in the form of fibrosis and sclerosis which 
directly cause increasing hypoxia in the da maged area 
creating a positive feedback loop [1, 5–8].
Another hypothesis considers one or several pa-
renchyma cell populations in the tissue as the lead-
ing factor of RIF pathogenesis. In normal conditions, 
cellular regenerating system creates a state of stable 
balance between cell populations, and in case of death 
or migration of a cell population, it produces new ele-
ments restoring cell number. During exposure to ion-
izing radiation, the character of radiation reactions 
reflects proliferative ability of the target cells. Organs 
and tissues containing vegetative and differentiat-
ing cells respond to irradiation with acute reactions. 
In other cell types, the changes are less pronounced 
or absent altogether. Therefore, RI developing during 
irradiation or soon after is characteristic of rapidly re-
generating tissues, and time to RI manifestation and 
its severity are determined by repopulation rate and 
cell radiosensitivity. For instance, irradiation of the 
skin (an example of rapidly regenerating tissue) leads 
to a decrease in the number of stem cells, or in other 
words, vegetative intermitotic cells. Then, the number 
of more differentiated cells — differentiating inter-
mitotic and constant postmitotic cells — decreases. 
Later, breakage of the base membrane is observed, 
as well as altered local blood flow and changes in the 
vessel walls. If the total absorbed dose is lower than 
the “tolerable dose” for the irradiated tissue, then 
the pathological process gradually subsides, and the 
number of stem cells is restored during the next dif-
ferentiation [1, 9, 10].
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When the absorbed dose exceeds tolerance of the 
tissue to ionizing radiation, a number of radiation-
induced changes occur leading to expansion of the 
connective tissue and formation of areas with in-
tense cicatricial transformation. According to both 
hypotheses, expansion of the connective tissue 
is a time-delayed process, and this tissue serves 
as a substitute. However, structural and functional 
characteristics of the connective tissue change long 
before the development of histologically observed 
symptoms of fibrosis. The main trigger for develop-
ment of local RI is damage to the fibroblasts, espe-
cially the immature, rapidly dividing populations that 
serve as the main structural element of the connec-
tive tissue. Current research is focused both on direct 
effect of radiotherapy on fibroblasts, and on the 
effects of the neighboring cells and factors during 
irradiation. Fibroblasts play a crucial role in wound 
healing by deposing and remodeling collagen fibers, 
and in the irradiated tissue the structure of these fibers 
becomes disorganized (due to possible dysregulation 
of matrix metalloproteases) [1, 11, 12].
Questions related to determination of individual 
sensitivity to ionizing radiation and pathogenesis of lo-
cal RI of the skin and subcutaneous fat, in particular 
after surgical treatment and radiation therapy in pa-
tients with breast cancer, remain open.
According to the “vessel hypothesis” of develop-
ment of late RI, the leading factor of pathogenesis 
is local alteration of tissue microcirculation. There-
fore, we decided to determine oxygen perfusion 
in the irradiated skin to confirm or rule out ischemia 
in this area.
Perfusion characterizes tissue respiration which, 
in turn, involves gas exchange, primarily of oxygen, 
in microcirculatory tissue systems, and redox reactions 
in mitochondria. The main physiological characteris-
tics of these processes are oxygen delivery and oxygen 
consumption [15].
Transcutaneous oxygen (tcpO2) measurement 
is non-invasive monitoring of partial oxygen pressure 
in the skin. Unlike arterial pressure and blood flow rate, 
tcpO2 is a direct measure of the state of microcircu-
lation and reflects real oxygen delivery to skin cells. 
Changes in the partial oxygen pressure tcpO2 show 
changes in oxygen transport, its delivery and con-
sumption and can help detect blood flow problems.
Principle of operation of a transcutaneous 
monitor. A set of sensors (Clark electrodes) placed 
on the skin measure blood gases entering the skin 
by diffusion. This method has gained widespread rec-
ognition due to its use in neonatology for evaluation 
of hypoxia in newborns and in treatment of trophic ulcers 
caused by diabetes mellitus. Moreover, transcutaneous 
oximeter (TO) can be used for controlling hyperbaric 
oxygenation and for optimization of implant survival.
Currently, non-invasive transcutaneous monitoring 
of tissue oxygen level tcpO2 (oxygenation/microcir-
culation and skin perfusion) is a valuable and reliable 
diagnostic instrument [16].
The aim of the study was to evaluate oxygen perfu-
sion in the skin in the area of late RI manifested as RIF 
in patients with breast cancer using TO TCM 400 (Ra-
diometer, Denmark).
MATERIALS AND METHODS
Evaluation of transcutaneous local partial oxygen 
tissue saturation tcpO2 using TO TCM 400 (Radio-
meter, Denmark) had been performed at the Regional 
Oncology Dispensary from September 2016 to May 
2017. The study included 19 patients with breast can-
cer (stages I–III a), tcpO2 was measured in the area 
of previous surgical treatment and irradiation and sub-
sequent RI in the form of RIF. In the studied patients, 
time since the completion of radiotherapy to the mea-
surement varied from 4 to 9 months. Patients’ age was 
from 27 to 65 years. All of the patients were informed 
about the objective of the study before they were in-
cluded and we have obtained the patients’ informed 
consent. Sensors of partial oxygen tissue saturation 
tcpO2 were placed on the front axillary line in the area 
of RIF. The measurement was compared to partial 
oxygen tissue saturation tcpO2 of an equivalent healthy 
non-irradiated tissue (a point on the frontal axillary 
line). During measurement point selection, a point 
above a homogenous capillary bed without large 
veins, skin defects, hair growth, or symptoms of sig-
nificant tissue edema was chosen. To obtain significant 
comparable data, standard conditions were used: 
1) environmental temperature was between 21 and 
24 °С; 2) before the examination patients didn’t smoke 
or ingest strong tea or coffee; 3) patients were stable 
(didn’t perform physical exercises).
The main locations of late RI were the frontal rib cage 
(11 patients, 57.9%) and mammary gland (8 patients, 
42.1%). Severity of RI was evaluated using the LENT-
SOMA (Late Effects Normal Tissues — Subjective, 
Objective, Management and Analytic) scale. The scale 
provides a detailed description of clinical symptoms 
in organs and tissues in the irradiated area: grade 1 — 
mild symptoms, no treatment need; grade 2 — symp-
toms more pronounced, require conservative treatment; 
grade 3 — severe symptoms significantly affecting 
quality of life, sometimes require surgical treatment; 
grade 4 — irreversible ulcerous and necrotic changes 
in soft tissues requiring surgical treatment [13].
In 7 patients with breast cancer, radiation- induced 
injury was grade 3 (36.84%), in 10 patients — 
grade 2 (52.63%), and in 2 patients — grade 1 (10.53%).
RESULTS
Partial oxygen pressure tcpO2 in the RIF area 
in patients with breast cancer didn’t show a signifi-
cant decrease compared to healthy tissue (Fig. 1). 
Mean value of partial oxygen pressure tcpO2 in the RIF 
area was 42.650 ± 9.178 mmHg, in the healthy tissue 
it was 45.180 ± 8.025 mmHg. Normally, in healthy 
people partial oxygen pressure tcpO2 in the chest 
is 67 ± 12 mmHg. Ischemia is diagnosed at values 
below 20 mmHg [14]. Maximal difference in tcpO2 be-
tween the damaged and healthy tissue was 30 mmHg.
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Comparison of transcutaneous partial pressure 
of oxygen didn’t show statistically significant differ-
ences between the mean values in the affected and 
healthy sides (Fig. 2). Per the Wilcoxon signed-rank 
test, there are no significant differences (p = 0.338) 
between healthy tissue and tissue affected by RIF.
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Fig. 2. Box plot of tсpО2 (mmHg) in tissues with late RI (RIF area) 
and healthy tissues (* — outlier, # — extremum)
DISCUSSION AND CONCLUSIONS
In accordance with several theories on pathoge-
nesis, RI of the skin and subcutaneous fat causes:
•	deficit of vegetative and differentiating intermitotic 
cells, fibroblasts in particular;
•	disorganization of collagen fibers in the irradiated area;
•	microcirculation disorder and hypoxia in the affected 
area.
Altered tissue microcirculation leads to decreased 
oxygenation and perfusion due to decreased oxygen 
delivery. According to the “vessel hypothesis” [18–20] 
of late RI pathogenesis, it is reasonable to assume 
a similar situation.
This assumption was the basis for evaluation of skin 
perfusion in the area of RIF and subsequent comparison 
of the data with equivalent healthy skin. For the study, 
we have chosen non-invasive monitoring of partial pres-
sure of oxygen and, for the first time, evaluated oxygen 
perfusion of the skin using TO TCM 400 (Radiometer, 
Denmark) in the area of late RI manifested as RIF in pa-
tients with breast cancer.
However, the obtained results show the absence 
of significant difference between the values obtained 
during measurement of oxygen perfusion of the skin 
(tcpO2) in the area of RIF (42.650 ± 9.178 mmHg) and 
healthy tissue (45.180 ± 8.025 mmHg). Based on the 
obtained data, microcirculation in the irradiated area 
is not affected. In all likelihood, the main cause of RIF 
in the irradiated area is deficit and depletion of vegeta-
tive and differentiating intermitotic cells (fibroblasts) 
rather than RI of capillary endothelium.
According to the conclusions of some researches, 
frequency and severity of RIF significantly depend 
on cumulative absorbed dose and time after radia-
tion therapy. The more time passes since irradiation, 
the higher is probability of severe fibrosis [1, 17]. 
Presumably, deficit of vegetative and intermitotic 
fibroblasts and disorganization of collagen fibers 
cause tissue hypoxia in the irradiated area, and al-
tered microcirculation is a subsequent event in the 
complex mechanism of pathogenesis of RIF. The 
obtained data shed a light on the development of late 
RI and show the necessity of further investigation 
of the problem.
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